# A Study Evaluating the Effect of Botulinum Toxin Type A on Semen Quality in Patients With Benign Prostatic Hyperplasia

> **NCT00894517** · PHASE1,PHASE2 · COMPLETED · sponsor: **Allergan** · enrollment: 61 (actual)

## Conditions studied

- Benign Prostatic Hyperplasia

## Interventions

- **BIOLOGICAL:** Botulinum Toxin Type A
- **DRUG:** Placebo (saline)

## Key facts

- **NCT ID:** NCT00894517
- **Lead sponsor:** Allergan
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-08
- **Primary completion:** 2012-06
- **Final completion:** 2012-08
- **Target enrollment:** 61 (ACTUAL)
- **Last updated:** 2013-09-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00894517

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00894517, "A Study Evaluating the Effect of Botulinum Toxin Type A on Semen Quality in Patients With Benign Prostatic Hyperplasia". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00894517. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*